316 related articles for article (PubMed ID: 28373362)
1. Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development.
Dreyer SB; Chang DK; Bailey P; Biankin AV
Clin Cancer Res; 2017 Apr; 23(7):1638-1646. PubMed ID: 28373362
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer genomics.
Chang DK; Grimmond SM; Biankin AV
Curr Opin Genet Dev; 2014 Feb; 24():74-81. PubMed ID: 24480245
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
5. Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies.
Meti N; Kelly D; Allen MJ; Lanys A; Fazelzad R; Ramjeesingh R; Zogopoulos G; Notta F; Knox JJ; Amir E; Gallinger S; O'Kane G; Grant RC
Cancer Treat Rev; 2021 Dec; 101():102310. PubMed ID: 34757307
[TBL] [Abstract][Full Text] [Related]
6. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
7. Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer.
Pishvaian MJ; Brody JR
Oncology (Williston Park); 2017 Mar; 31(3):159-66, 168. PubMed ID: 28299752
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.
Dreyer SB; Jamieson NB; Evers L; Duthie F; Cooke S; Marshall J; Beraldi D; Knight S; Upstill-Goddard R; Dickson EJ; Carter CR; McKay CJ; Biankin AV; Chang DK
Chin Clin Oncol; 2019 Apr; 8(2):16. PubMed ID: 31070037
[TBL] [Abstract][Full Text] [Related]
9. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
Friedman K; Resnick MB; Safran H
R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
[TBL] [Abstract][Full Text] [Related]
10. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.
Malgerud L; Lindberg J; Wirta V; Gustafsson-Liljefors M; Karimi M; Moro CF; Stecker K; Picker A; Huelsewig C; Stein M; Bohnert R; Del Chiaro M; Haas SL; Heuchel RL; Permert J; Maeurer MJ; Brock S; Verbeke CS; Engstrand L; Jackson DB; Grönberg H; Löhr JM
Mol Oncol; 2017 Oct; 11(10):1413-1429. PubMed ID: 28675654
[TBL] [Abstract][Full Text] [Related]
12. Understanding pancreatic cancer genomes.
Cowley MJ; Chang DK; Pajic M; Johns AL; Waddell N; Grimmond SM; Biankin AV
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):549-56. PubMed ID: 23660961
[TBL] [Abstract][Full Text] [Related]
13. Newer Trends in Pancreatic Cancer Treatment: Genetic Alterations and the Role of Immune Therapeutic and Targeted Therapies.
Hussain I; Rashid MU; Sarvepalli D; Rahman AU; Ullah W; Badar H; Jehanzeb S; Khan AK; Khan MT; Muzammil M; Ahmad S
Crit Rev Oncog; 2019; 24(2):157-177. PubMed ID: 31679211
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer genomics: where can the science take us?
Graham JS; Jamieson NB; Rulach R; Grimmond SM; Chang DK; Biankin AV
Clin Genet; 2015 Sep; 88(3):213-9. PubMed ID: 25388820
[TBL] [Abstract][Full Text] [Related]
16. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.
Hu HF; Ye Z; Qin Y; Xu XW; Yu XJ; Zhuo QF; Ji SR
Acta Pharmacol Sin; 2021 Nov; 42(11):1725-1741. PubMed ID: 33574569
[TBL] [Abstract][Full Text] [Related]
17. From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.
Kyrochristos ID; Glantzounis GK; Ziogas DE; Gizas I; Schizas D; Lykoudis EG; Felekouras E; Machairas A; Katsios C; Liakakos T; Cho WC; Roukos DH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106782
[TBL] [Abstract][Full Text] [Related]
18. [A Novel Treatment Strategy for Pancreatic Cancer Based on Gene Profiles].
Hayashi H; Nishihara H
Gan To Kagaku Ryoho; 2016 Nov; 43(11):1326-1331. PubMed ID: 27899773
[TBL] [Abstract][Full Text] [Related]
19. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience.
Lowder CY; Dhir T; Goetz AB; Thomsett HL; Bender J; Tatarian T; Madhavan S; Petricoin EF; Blais E; Lavu H; Winter JM; Posey J; Brody JR; Pishvaian MJ; Yeo CJ
Surg Oncol; 2020 Jun; 33():118-125. PubMed ID: 32561076
[TBL] [Abstract][Full Text] [Related]
20. Applying next-generation sequencing to pancreatic cancer treatment.
Mardis ER
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):477-86. PubMed ID: 22751458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
